Author

Haiyan Sun

Arizona State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrian Esqueda· 1 shared Ayijiang YisimayiiD· 1 shared Fanchong JianiD· 1 shared Fei Shao· 1 shared Herta Steinkelner· 1 shared Jing WangiD· 1 shared Lingling Yu· 1 shared Miaomiao Ma· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adrian Esqueda

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Role of Nonneutralizing Antibodies and Fc Effector Functions in Inhibiting SARS-CoV-2 Infection

Haiyan Sun, Adrian Esqueda, Herta Steinkelner, Qiang Chen

This study compares the antiviral activities of neutralizing and non-neutralizing mAbs against SARS-CoV-2, showing that Fc glycosylation significantly impacts antiviral efficacy through ADCC and ADCVI.

bioRxiv · Apr 9, 2026 · PreprintImmunology

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

Fanchong Jian, Jing Wang, Ayijiang Yisimayi, Weiliang Song, Yanli Xu, Xiaosu Chen, Xiao Niu, Sijie Yang, Yuanling Yu, Peng Wang, Haiyan Sun, Lingling Yu, Yao Wang, Ran An, Wenjing Wang, , Yunlong Cao

This study analyzes the humoral immune response to SARS-CoV-2 XBB and JN.1 lineages, showing JN.1 elicits superior neutralization and highlights the need for JN.1-based vaccine boosters.

bioRxiv · Apr 19, 2024Immunology